New research shows current lung cancer screening guidelines may need to expand, and a second study finds even those eligible for screening are not receiving the lifesaving surveillance. Jarred Hill ...

A recently approved group of drugs - immune checkpoint inhibitors - can boost the body's ability to eliminate a tumor and ...

A new study of adolescents and young adults (AYAs) with seven common cancers reveals that nearly one in ten patients diagnosed with non-metastatic disease later develop metastatic recurrence - a ...

A new study led by researchers at UCLA Health has given doctors and patients clearer guidance on how long hormone therapy, ...

The study found that nerves in the digestive system—sometimes called the “second brain”—play a surprising role in helping ...

Diabetes and cancer are two of the four major non-communicable diseases identified by WHO. Their relationship is multifaceted ...

The research highlights the role of immune checkpoint inhibitors, drugs that enhance the body's ability to fight tumors.

In a proof-of-concept, placebo-controlled trial, the investigational oral selective AKT inhibitor engasertib appeared to be ...

For some patients with the most common type of lung cancer, known as lung adenocarcinoma, there's new hope. In a new study ...

A study of U.S. veterans in California found seniors with diabetes or heart disease have an increased risk of death during hot weather.

The FDA approved perioperative durvalumab (Imfinzi) in combination with a multidrug chemotherapy regimen for resectable ...